Upgrade to SI Premium - Free Trial

Ascendis Pharma (ASND) Reports Q2 EPS by EUR (1.46)

August 10, 2022 4:12 PM

Ascendis Pharma (NASDAQ: ASND) reported Q2 EPS of EUR(1.46).

For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.

Categories

Corporate News Earnings

Next Articles